BNTX
Biontech SE
A German biotechnology company that builds medicines from messenger RNA (mRNA), best known for the COVID-19 vaccine it developed with Pfizer. Its scientists in Mainz also focus on personalized cancer therapies, tailoring treatments to each patient's tumor. It was founded in 2008 by immunologists Uğur Şahin and Özlem Türeci, a married couple who met in a hospital lab, and the name blends "bio" with "NT" for "New Technologies."
ADRUnderlying: BNTXCUSIP: 09075V102HealthcareDE3 holders
American Depositary Share
Total Value
$367.74M
Total Shares
3.94M
Net Share Change
+133.2K
Activity
3 buying
Investor
Value
Shares
Weight
Change
